Cart
sales@molnova.com
L-Methionine-DL-sulfoximine
CAS No. 15985-39-4
L-Methionine-DL-sulfoximine( MSX | MSO )
Catalog No. M28359 CAS No. 15985-39-4
L-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 40 | In Stock |
|
| 50MG | 58 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-Methionine-DL-sulfoximine
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
-
DescriptionL-Methionine-DL-sulfoximine inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies.
-
In Vitro——
-
In Vivo——
-
SynonymsMSX | MSO
-
PathwayOthers
-
TargetOther Targets
-
RecptorCCR8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15985-39-4
-
Formula Weight180.22
-
Molecular FormulaC5H12N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (277.42 mM)
-
SMILESCS(=N)(=O)CC[C@H](N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jenkins TJ, et al. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem. 2007;50(3):566-584.
molnova catalog
related products
-
Catalase
Catalase is an essential enzyme in the metabolism of H2O2 and reactive oxygen species (ROS).
-
γ-Glu-Phe TFA(7432-2...
γ-Glu-Phe TFA (γ-Glutamylphenylalanine TFA) is synthesized from bacillus amyloliquefaciens (GBA) and aspergillus oryzae (GAO).
-
DFP00173
DFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM.
